Keppra

Keppra

levetiracetam

Manufacturer:

GlaxoSmithKline Indonesia
Concise Prescribing Info
Contents
Levetiracetam
Indications/Uses
Adjunctive treatment of partial onset of seizures w/ or w/o secondary generalisation in patient w/ epilepsy.
Dosage/Direction for Use
Daily dose is administered in 2 equally divided doses. Adult & adolescent ≥16 yr Initially 500 mg twice daily, may be increased up to 1,500 mg twice daily. Dose changes can be made in 500 mg twice daily increments or decrements 2-4 wkly.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to levetiracetam or other pyrrolidones derivatives.
Special Precautions
Abrupt discontinuation. Renal & severe hepatic impairment. May affect ability to drive or operate machinery. Pregnancy & lactation. Elderly.
Adverse Reactions
Asthenia; somnolence; headache, dizziness, tremor; depression, insomnia, nervousness; diarrhoea, dyspepsia, nausea; anorexia; vertigo; diplopia; accidental injury.
MIMS Class
ATC Classification
N03AX14 - levetiracetam ; Belongs to the class of other antiepileptics.
Presentation/Packing
Form
Keppra FC tab 250 mg
Packing/Price
30's
Form
Keppra FC tab 500 mg
Packing/Price
20's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in